Mirari Márquez

2.8k total citations
20 papers, 468 citations indexed

About

Mirari Márquez is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Mirari Márquez has authored 20 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Mirari Márquez's work include Bladder and Urothelial Cancer Treatments (10 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Screening and Detection (3 papers). Mirari Márquez is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Screening and Detection (3 papers). Mirari Márquez collaborates with scholars based in Spain, United States and Netherlands. Mirari Márquez's co-authors include Núria Malats, Francisco X. Real, Ferrán Algaba, André F.S. Amaral, Emily G. Armitage, Antonia Garcı́a, Emanuel Carrilho, José A. Lorente, Coral Barbas and Ellen C. Zwarthoff and has published in prestigious journals such as PLoS ONE, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Mirari Márquez

20 papers receiving 459 citations

Peers

Mirari Márquez
Minhhuyen T. Nguyen United States
Sheila Harris United Kingdom
Ido Laskov Israel
Ya Zheng China
J Tošner Czechia
Michael J. Higgs United Kingdom
Dante diTommaso United States
Minhhuyen T. Nguyen United States
Mirari Márquez
Citations per year, relative to Mirari Márquez Mirari Márquez (= 1×) peers Minhhuyen T. Nguyen

Countries citing papers authored by Mirari Márquez

Since Specialization
Citations

This map shows the geographic impact of Mirari Márquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirari Márquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirari Márquez more than expected).

Fields of papers citing papers by Mirari Márquez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirari Márquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirari Márquez. The network helps show where Mirari Márquez may publish in the future.

Co-authorship network of co-authors of Mirari Márquez

This figure shows the co-authorship network connecting the top 25 collaborators of Mirari Márquez. A scholar is included among the top collaborators of Mirari Márquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirari Márquez. Mirari Márquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Earl, Julie, Jessica Encinas, María E. Castillo, et al.. (2020). A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine. 53. 102675–102675. 33 indexed citations
2.
Masson-Lecomte, A., Pascale Maillé, Sílvia Pineda, et al.. (2019). CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis. Bladder Cancer. 5(2). 159–169. 7 indexed citations
3.
Critselis, Elena, Marta Rava, Mirari Márquez, et al.. (2019). Diagnostic and Prognostic Performance of Secreted Protein Acidic and Rich in Cysteine (SPARC) Assay for Detecting Primary and Recurrent Urinary Bladder Cancer. PROTEOMICS - CLINICAL APPLICATIONS. 13(2). e1800148–e1800148. 7 indexed citations
4.
Rava, Marta, Debra T. Silverman, Mirari Márquez, et al.. (2017). Asthma status is associated with decreased risk of aggressive urothelial bladder cancer. International Journal of Cancer. 142(3). 470–476. 10 indexed citations
5.
Masson-Lecomte, A., Evangelina López de Maturana, Michael E. Goddard, et al.. (2016). Inflammatory-Related Genetic Variants in Non–Muscle-Invasive Bladder Cancer Prognosis: A Multimarker Bayesian Assessment. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1144–1150. 4 indexed citations
6.
Maturana, Evangelina López de, Antoni C. Picornell, A. Masson-Lecomte, et al.. (2016). Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models. BMC Cancer. 16(1). 351–351. 9 indexed citations
7.
Kessel, Kim E.M. van, Willemien Beukers, Irene Lurkin, et al.. (2016). Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy. The Journal of Urology. 197(3 Part 1). 590–595. 107 indexed citations
8.
Pineda, Sílvia, Paulina Gómez-Rubio, Antoni C. Picornell, et al.. (2015). Framework for the Integration of Genomics, Epigenomics and Transcriptomics in Complex Diseases. Human Heredity. 79(3-4). 124–136. 16 indexed citations
9.
Pineda, Sílvia, Roger L. Milne, M. Luz Calle, et al.. (2014). Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis. PLoS ONE. 9(5). e89952–e89952. 16 indexed citations
10.
Vedder, Moniek M., Mirari Márquez, Esther W. de Bekker‐Grob, et al.. (2014). Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours. PLoS ONE. 9(6). e96849–e96849. 44 indexed citations
11.
Tajuddin, Salman M., André F.S. Amaral, Agustín F. Fernández, et al.. (2014). LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk. British Journal of Cancer. 110(8). 2123–2130. 16 indexed citations
12.
Amaral, André F.S., Emily G. Armitage, José A. Lorente, et al.. (2013). Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography–mass spectrometry and capillary electrophoresis–mass spectrometry metabolomics approach. Journal of Chromatography A. 1318. 163–170. 111 indexed citations
13.
Bernal‐Delgado, Enrique, Carmen Martos, María Dolores Chirlaque, et al.. (2010). Is hospital discharge administrative data an appropriate source of information for cancer registries purposes? Some insights from four Spanish registries. BMC Health Services Research. 10(1). 9–9. 26 indexed citations
14.
Hernando-Arizaleta, Lauro, et al.. (2009). Impacto de la inmigración sobre la asistencia hospitalaria: frecuentación, casuística y repercusión económica. Hispana. 13 indexed citations
15.
Hernando-Arizaleta, Lauro, et al.. (2009). Impacto de la inmigración sobre la asistencia hospitalaria: frecuentación, casuística y repercusión económica. Gaceta Sanitaria. 23(3). 208–215. 14 indexed citations
16.
Avanzini, Fausto, Mariella Anselmi, Sofía Ibarra, et al.. (2008). Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification. BMJ. 337(sep19 1). a1387–a1387. 7 indexed citations
17.
Chirlaque, M.D., Carmen Navarro, & Mirari Márquez. (2008). DataLink Record Linkage Software Applied to the Cancer Registry of Murcia, Spain. Methods of Information in Medicine. 47(5). 448–453. 5 indexed citations
18.
Márquez, Mirari, et al.. (2006). Validación de los códigos diagnósticos de cáncer de colon y recto del Conjunto Mínimo Básico de Datos. Gaceta Sanitaria. 20(4). 266–272. 13 indexed citations
19.
Márquez, Mirari, et al.. (2004). Prevalencia de presión arterial elevada y otros factores de riesgo de enfermedad cardiovascular en trabajadores de cafetines de la Universidad Central De Venezuela (Ciudad Universitaria). 27(2). 142–150. 1 indexed citations
20.
Márquez, Mirari, et al.. (2000). [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].. PubMed. 17(10). 562–3. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026